Prothena Profit Margin 2011-2021 | PRTA
Current and historical gross margin, operating margin and net profit margin for Prothena (PRTA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Prothena net profit margin as of September 30, 2021 is 34.76%.
|Prothena Annual Profit Margins
|Prothena Quarterly Profit Margins
||Medical - Biomedical and Genetics
Prothena Corporation plc is a biotechnology company focused on the discovery and development of therapeutic monoclonal antibodies for disease-causing proteins. The Company is developing the following programs: NEOD001 for Amyloidosis, NEOD002 for Parkinson's disease, MCAM for Inflammatory disease and Metastatic Cancer and Tau for Alzheimer's disease. Prothena Corporation plc is headquartered in Dublin, Ireland.